Hence, these circulating adipokines were analyzed in the serum of breast cancer survivors to determine their potential as a biomarker for lymphedema; additionally, the adiponectin/leptin ratio was calculated to evaluate the degree of association of metabolic syndrome with BCRL. The gene discussed is LEP; the disease is breast cancer.